US Patent Issued to Atossa Therapeutics on March 17 for "Heparin and N-acetylcysteine for the treatment of lung injury" (Washington Inventor)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,103, issued on March 17, was assigned to Atossa Therapeutics Inc. (Seattle).

"Heparin and N-acetylcysteine for the treatment of lung injury" was invented by Steven C. Quay (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions and methods for treatment or prevention of a respiratory viral infection. A composition of the present disclosure comprises one or more of heparin, or N-acetylcysteine. A composition for treatment or prevention of a respiratory viral infection may be administered by inhalation in intervals. Administration of a composition may treat or prevent a viral infection."

The patent was filed on Marc...